Biobizkaia Health Research Institute
If you are the contact person for this centre and you wish to make any changes, please contact us.
Screening Coordinator at Osakidetza -Basque Health Service, researcher in the Cancer Biomarkers group at the Biobizkaia Health Research Institute, and secretary of the Board of Directors of the Spanish Epidemiology Society
Ikerbasque Research Professor, director of the Laboratory of Neural Reprogramming and Regeneration (Molecular Brain Lab) and assistant to the scientific director of the Health Research Institute Biobizkaia
Two studies published in the New England Journal of Medicine evaluate colorectal cancer screening tests that could be alternatives to the existing faecal immunochemical test (FIT), which detects occult blood in stool. The first study uses a new generation test that detects DNA in stool and has a higher sensitivity than FIT, 93.9% for colorectal cancer and 90.6% for advanced neoplasia (tumour formation). The second uses a blood-based DNA detection test with a sensitivity of 83% for colorectal cancer and 90% for advanced neoplasia.